SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen D. Wilson who wrote (810)6/3/1999 9:45:00 AM
From: johnny weissman  Read Replies (4) of 1386
 
Knowledgeable people on this thread have various explanations for PARS'--what's the word?... execrable--performance. Here's mine: PARS is a penny stock. It cannot hold its gains. That category, that identity in the stock world, over-rides the company/sector reality. Only a buy-out can jack this stock up, imo. Like most stocks, it probably has no right to have gone public. This is despite any good work it's doing. Only a very few people will ever benefit from PARS being a public company. I hope I eat my words someday ...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News